SEB Biotech Seminar

At SEB in Stockholm, Sweden. CEO Jakob Lindberg presents Oncopeptides AB.

Year-end Report 2018

Oncopeptides AB will release its Year-end Report on 22 February at 8:00 am CET. 

Annual General Meeting 2019

The AGM of Oncopeptides AB (Publ) will be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden,Tuesday May 21, 2019, at 14.00 CET.

Avanza Börsdag

Stockholm, Sweden Oncopeptides will hold a presentation at 10.15 CET, which will be webcasted. See link below.

Webcast to review the Interim Report Q2 2019

The Interim Report Q2 2019 and an operational update will be presented by CEO Jakob Lindberg and members of Oncopeptides management team, Wednesday August 28, 2019 at 15:00 (CET). The conference call...

International Myeloma Workshop (IMW) 2019

In Boston. Oncopeptides to present: Two Poster presentations - Quality of life of treatment for relapsed/refractory multiple myeloma: a systematic review - Aminopeptidase gene expression in myeloma And Oral...

Webcast to review of the results presented at the IMW

CEO Jakob Lindberg will review of the results presented at IMW, on Monday September 16, 2019 at 08:30 (CET). The conference call will also be streamed via a link on the company website:

Recap ASH

Webcast at 13.00 (CET)